Cargando…

PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM

Detalles Bibliográficos
Autores principales: Kolodny, Scott, Vredenburg, Michael, Zhang, Jessica, Jamieson, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428788/
http://dx.doi.org/10.1097/01.HS9.0000977176.66781.66
_version_ 1785090553775390720
author Kolodny, Scott
Vredenburg, Michael
Zhang, Jessica
Jamieson, Brian
author_facet Kolodny, Scott
Vredenburg, Michael
Zhang, Jessica
Jamieson, Brian
author_sort Kolodny, Scott
collection PubMed
description
format Online
Article
Text
id pubmed-10428788
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104287882023-08-17 PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM Kolodny, Scott Vredenburg, Michael Zhang, Jessica Jamieson, Brian Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428788/ http://dx.doi.org/10.1097/01.HS9.0000977176.66781.66 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Kolodny, Scott
Vredenburg, Michael
Zhang, Jessica
Jamieson, Brian
PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM
title PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM
title_full PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM
title_fullStr PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM
title_full_unstemmed PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM
title_short PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM
title_sort pb2622: a prospective, open-label ongoing study of safety and treatment satisfaction in adult immune thrombocytopenia (itp) subjects after switching to avatrombopag from eltrombopag or romiplostim
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428788/
http://dx.doi.org/10.1097/01.HS9.0000977176.66781.66
work_keys_str_mv AT kolodnyscott pb2622aprospectiveopenlabelongoingstudyofsafetyandtreatmentsatisfactioninadultimmunethrombocytopeniaitpsubjectsafterswitchingtoavatrombopagfromeltrombopagorromiplostim
AT vredenburgmichael pb2622aprospectiveopenlabelongoingstudyofsafetyandtreatmentsatisfactioninadultimmunethrombocytopeniaitpsubjectsafterswitchingtoavatrombopagfromeltrombopagorromiplostim
AT zhangjessica pb2622aprospectiveopenlabelongoingstudyofsafetyandtreatmentsatisfactioninadultimmunethrombocytopeniaitpsubjectsafterswitchingtoavatrombopagfromeltrombopagorromiplostim
AT jamiesonbrian pb2622aprospectiveopenlabelongoingstudyofsafetyandtreatmentsatisfactioninadultimmunethrombocytopeniaitpsubjectsafterswitchingtoavatrombopagfromeltrombopagorromiplostim